As a massive winter storm barrels across the U.S., power grid operators are taking extraordinary steps to keep the lights on and avoid rolling blackouts. The storm, stretching more than 2,300 miles, ...

America’s AI boom is pushing the nation’s largest power-grid operator to the brink of a supply crisis. Sixty-seven million people in a 13-state region stretching from New Jersey to Kentucky get their ...

The U.S. power grid is indispensable infrastructure for our economy, but warning signs are flashing about its health that should concern every business leader in our country. Skyrocketing growth in ...

Factorial’s high-power, lightweight, solid-state batteries have demonstrated real-world performance, including over 1,200 km (745 miles) of driving range in vehicle testing and are being advanced ...

An early grid battery was installed in the Atacama Desert in Chile 15 years ago. Now, as prices have tumbled, they are increasingly being used around the world. Andes Solar IV, one of the largest ...

Artificial Intelligence (AI) is now a major force in the U.S. economy. The rapid expansion of data centers in the United States has emphasized the challenges facing the U.S. electricity sector, which ...

Massive data centers are pushing energy demand higher. Some people claim that AI will be a net benefit for the grid. The rising popularity of AI is driving an increase in electricity demand so ...

Championship leader Alex Palou wins pole position for the IndyCar Series race at WeatherTech Raceway at Laguna Seca, his fifth pole of the season. Pato O'Ward — second in the points but not all that ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases, eliminating the need for preconditioning chemotherapy. Lead candidate Descartes-08 showed promising ...

U.S. power infrastructure—the intricate physical fabric that laces together generation, transmission, and distribution—is under intensifying strain. Outdated and overextended, it must now absorb ...

Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis (MG ...